IDIBELL on the media

E2MBAZTHHJOTXGM3GRED2W54H4 (1)

WORLD CANCER DAY: The most common tumors in women are breast, colorectal and corpus uteri and in men, prostate, lung and colorectal

February 4th is World Day against Cancer. In Catalonia, this disease is the most common cause of death in men and the second in women. The World Health Organization dedicates the day, like last year, to break myths about the disease. You can view the most common myths by clicking here. During 2013 the Catalan […]

Figure 4-AGA final

Researchers discover an epigenetic mark that could be useful for classifying leukemic origin and disease relapse

An international study between the Imprinting and Cancer Group within the Cancer Epigenetics and Biology Program (PEBC) and the Institute of Human Genetics, at Christian-Albrechts University, Kiel, Germany, describe a methylation signature that is a promising marker for classifying myeloid-derived leukemias. Gene Wilms tumor 1 (WT1) is over-expressed in numerous cancers with respect to normal […]

premi-vanguardia-2013

Manel Esteller,Vanguardia Science Award

The researcher Manel Esteller, Director of Epigenetics and Cancer Biology program at the Institute of Biomedical Research of Bellvitge (IDIBELL ), ICREA researcher and professor of Genetics at the University of Barcelona has won the Vanguardia Award for Science 2013. The selected job has been published in 2013 in the journal Genome Research and shows […]

arevalo

Gonzalo Arévalo: ”10% of H2020 funding goes directly to Health but there are other areas that can provide opportunities for researchers”

The first calls of the European Horizon 2020 program have begun. On 17 January, the National Contact Point for Legal and Financial Affairs also part of the team of the Office of European Institute of Health Carlos III Project, Gonzalo Arévalo told investigators IDIBELL funding opportunities that may represent Horizon 2020 (H2020). “Between 25 and […]

grup_gabi

An international study allows a better prediction of the risk of hereditary cancer

The paper analyzes the role of different genetic variants involved in Lynch syndrome , an inherited disease that increases the risk of various tumors The study is published in the journal Nature Genetics and has had the participation of Gabriel Capellá and Marta Pineda, form the Hereditary Cancer Program at the Catalan Institute of Oncology […]

cape-town-gb3659d4c3_1920 (1)

About 7 % of the general population suffers from compulsive buying disorder

Men and women alike Risk Factors

max

Researchers discover a tumor suppressor gene in a very aggressive lung cancer

The Genes and Cancer Group at the Cancer Epigenetics and Biology Program of the IDIBELL has found that the MAX gene, which encodes a partner of the MYC oncogene, is genetically inactivated in small cell lung cancer. Reconstitution of MAX significantly reduced cell growth in the MAX-deficient cancer cell lines. These findings show that MAX […]

quimioterapia

Researchers propose an alternative therapy to fight testicular cancer refractory to chemotherapy

Researchers at Tumor angiogenesis group at Bellvitge Biomedical Institute of Research (IDIBELL) and the Catalan Institute of Oncology (ICO) led by Francesc Viñals have published a study in the journal Clinical Cancer Research where they propose an alternative treatment to cisplatin resistant testicular cancer patients . 90 % cure rate of testicular tumors Testicular tumor […]

grup-conxi-lazaro

A free web application developed by the ICO-IDIBELL enables data analysis new generation sequencing

The last two years have seen a significant change in the field of genetic diagnosis , mainly due to the application of technologies next generation sequencing (NGS , next generation sequencing) in medium-capacity devices. The development of these instruments, together with the launch of commercial kits to study a limited number of genes, has allowed […]

horizon2020_0

Horizon 2020 launched with €15 billion over first two years

The European Commission has for the first time presented calls for projects under Horizon 2020, the European Union’s €80 billion research and innovation programme. Worth more than €15 billion over the first two years, the funding is intended to help boost Europe’s knowledge-driven economy, and tackle issues that will make a difference in people’s lives. […]

Scroll to Top